This is worrying (and it isn't caused by the Covid vaccines before anyone even thinks of trying to blame them).
Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing Quote:Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, sees something different in his practice since the onset of the COVID-19 pandemic—not just with cancer care, but with cancer itself.
Since March 2020, the longtime community oncologist has seen multiple patients in his Rock Hill, South Carolina, based-clinic with cholangiocarcinoma, and these patients are developing the rare cancer 20 to 30 years earlier than the typical age at presentation, which is usually 65 years or older. In the past year alone, physicians in Patel’s practice saw 7 patients with this cancer, and 3 have died.
It is not just a single cancer type, either. Patel and his colleagues, both in the United States and those he knows overseas, have seen patients with rapidly progressing cancers of several types, such as breast cancer and renal cell carcinoma. During an interview with Evidence-Based Oncology™(EBO), Patel said several did not even have time to receive treatment and died within weeks of diagnosis.
Quote:Among these was a patient aged 26 years with rapidly progressing triple-negative breast cancer. Another patient developed systemic inflammatory response syndrome, which can be caused by an infection, inflammation, or pancreatitis, and is often seen in patients with lung cancer. The patient was 51 when he died 4 weeks after receiving a diagnosis, making him 15 years younger than the typical patient with this condition.
Patel said one his colleagues told him that he cannot keep up with the volume of new patients presenting with prostate cancer at his practice in India.
“The trend is getting more and more alarming,” Patel emphasized. “We are noticing trends in hematological malignancies, breast cancer, colorectal carcinoma, and pancreatic cancer.”
Quote:Patel is now on a mission to put concrete numbers to what he acknowledges are clinic-level observations, and to find a way to help patients most at risk. There is evidence to support Patel’s observation that SARS-CoV-2 can set off inflammatory responses in tumors, causing cancer to progress much sooner and more aggressively, and even reawaken dormant cancer cells.
Forum
Pages: 
